Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A3 pseudogene 1 (EIF4A3P1) is classified as a pseudogene. Pseudogenes arise from functional genes through duplication or retrotransposition events but generally lose their coding potential due to mutations or lack of regulatory elements. EIF4A3P1 shares sequence homology with the functional gene EIF4A3, which encodes an ATP-dependent RNA helicase involved in mRNA splicing and the exon junction complex. However, EIF4A3P1 does not produce a functional protein and has no established biological or therapeutic roles[2]. While some pseudogenes exert regulatory influences or serve as non-coding RNAs, there is currently no reported function or disease association for EIF4A3P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A3 pseudogene 1 (EIF4A3P1).